Top 20 Companies in Global Inhalation Anesthesia Market (2025–2035): Spherical Insights Analysis
RELEASE DATE: Apr 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Inhalation Anesthesia Market. Size Is Projected To Grow From USD 1.65 Billion In 2024 To USD 3.39 Billion By 2035, At A CAGR Of 6.76% During The Forecast Period 2025–2035. The global inhalation anesthetic market is propelled by the increased rate of surgeries caused by chronic diseases, the aging population, and increased access to healthcare in the emerging world.
Introduction
The inhalation anesthesia involves the use of respiratory volatile anesthetic agents, which are utilized to ensure patient sedation, analgesia, and muscle relaxation, thus facilitating general anesthesia. The inhalation anesthesia method has been commonly employed in various operating rooms, ambulatory surgeries, and emergency situations. The global inhalation anesthetic market is moving forward with the advent of AI-based predictive analytics, computer-assisted anesthetic delivery systems, and low-flow anesthetic systems, which are proving to be more accurate and reducing wastage of anesthetic gases while providing better patient safety. In addition, the development of eco-friendly anesthetic agents is also gaining momentum. The growth drivers in the inhalation anesthetic market are the high growth rate of ambulatory surgical centers, investments in the healthcare sector.
The European Society of Anaesthesiology and Intensive Care, representing over 40,000 professionals across 100+ countries, plays a pivotal role in setting clinical standards, significantly influencing safety practices and sustainability trends in the global inhalation anesthesia market.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Inhalation Anesthesia Market
Inhalation Anesthesia Market Size & Statistics
- The Market Size for Inhalation Anesthesia Market Was Estimated to be worth USD 1.65 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 6.76% between 2025 and 2035.
- The Global Inhalation Anesthesia Market Size is anticipated to reach USD 3.39 Billion by 2035.
- Europe is estimated to generate the highest demand during the forecast period in the Global Inhalation Anesthesia Market.
- Asia-Pacific is projected to grow the fastest during the forecast period in The Inhalation Anesthesia Market.
Market Segmentation
Global Inhalation Anesthesia Market Size, Share, By Product Type (Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide, Others), By Delivery Method (Masks, Endotracheal Tubes, Laryngeal Mask Airways (LMAs)), By Application (General Surgery, Cardiac Surgery, Orthopedic Surgery, Cosmetic Surgery, Dental Procedures, Others)By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Others), And By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Regional growth and demand
Asia-Pacific is expected to grow the fastest during the forecast period in the Inhalation Anesthesia Market. It is caused by expanding healthcare infrastructure and rising surgical volumes across China and India. The demand for medical services has increased due to three factors which include the rising number of chronic diseases, the growing elderly population, and better access to specialized medical treatments. The regional market growth and investment potential receive support from three factors which include government programs, increasing healthcare spending, and quick implementation of advanced anesthetic systems.
India’s Ministry of Health & Family Welfare has strengthened perioperative safety via IPC guidelines, covering 70,000+ facilities, indirectly supporting the global inhalation anesthesia market through improved operating room standards, compliance, and infection control infrastructure.
Europe is anticipated to generate the highest demand during the forecast period in the Inhalation Anesthesia Market. It is because of the developed infrastructure and high surgical volumes. The adoption rate of advanced anesthetic delivery systems is expected to increase in Germany, France, and the UK. In addition, the aging population, along with stringent regulatory and reimbursement policies, is expected to ensure consistent growth in the European market, as the region is considered mature and growing.
NHS England eliminated routine desflurane use across 1,200+ hospitals, targeting emissions reduction of over 40,000 tonnes annually, significantly accelerating the global inhalation anesthesia market shift toward low-emission agents like sevoflurane and isoflurane.
Ready to lead the Inhalation Anesthesia Market ?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 trends in the Inhalation Anesthesia Market
- Rise of Low-Flow Anesthesia Techniques
- Environmental Sustainability and Phase-out of Desflurane
- Dominance of Sevoflurane in Pediatric and Geriatric Care
- Integration of AI in Anesthesia Delivery Systems
- Expansion of Ambulatory Surgical Centers (ASCs)
- Growth in Emerging Markets (Asia-Pacific)
- Increased Use in Intensive Care Units (ICUs)
- Adoption of Closed-Loop Anesthesia Systems
- Rising Focus on Cost-Effectiveness and Generics
- Development of Anesthesia Gas Recycling Systems
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Inhalation Anesthesia Market
1.Rise of Low-Flow Anesthesia Techniques
The Low flow anesthesia is being increasingly used in various health facilities with the aim of reducing the number of anesthetic agents required, which in turn reduces the costs and the environmental effects of volatile anesthetic agents. This technique reduces the fresh gas flow (FGF) while maintaining moisture and heat retention in the patients’ bodies at the same time.
2.Environmental Sustainability and Phase-out of Desflurane
The increasing environmental awareness has contributed to the move away from agents with a high global warming potential, such as desflurane, which is currently being phased out in countries such as the UK and parts of the US, and replaced with more environmentally friendly agents such as sevoflurane, to meet global climate sustainability goals.
3.Dominance of Sevoflurane in Pediatric and Geriatric Care
The sevoflurane is becoming the preferred inhaled anesthetic agent worldwide due to the benefits of rapid induction, rapid recovery, a pleasant smell, and low airway irritation. In addition, the safety of the agent has made it highly suitable for pediatric, geriatric, and outpatient procedures, thus becoming the market leader in the inhaled anesthetic agent’s market.
4.Integration of AI in Anesthesia Delivery Systems
The use of artificial intelligence is changing the way anesthesia is administered by allowing the real-time monitoring of the depth of anesthesia and the dosage of the drugs administered to the patients. This improves the safety of the patients by reducing the wastage of the drugs and the chances of human error during the procedures.
5.Expansion of Ambulatory Surgical Centers (ASCs)
The growing use of same-day, minimally invasive, and outpatient surgical procedures has created a huge demand for inhalation anesthetics, especially in ASCs, which are known for providing fast recovery and cost efficiency. This has been driven by the requirement for quick recovery times, and hence, agents such as sevoflurane are in huge demand.
Top 20 Companies Leading the Inhalation Anesthesia Market
- Baxter International Inc.
- AbbVie Inc.
- Fresenius Kabi AG
- Piramal Critical Care
- Halocarbon Products Corporation
- Hikma Pharmaceuticals PLC
- Merck KGaA
- Lunan Pharmaceutical Group
- Drägerwerk AG & Co. KGaA
- GE HealthCare
- Medtronic plc
- Mindray Medical International Limited
- Teleflex Incorporated
- Smith’s Group plc
- Sedana Medical AB
- VERO Biotech
- Midmark Corporation
- Troikaa Pharmaceuticals Ltd.
- Dechra Pharmaceuticals plc
- Linde plc
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Inhalation Anesthesia Market
- Baxter International Inc.
Headquarters: Deerfield, Illinois
The Baxter International Inc., and founded in 1931, has around 37,500 employees worldwide and reported revenue of around USD 11.2 billion in 2025. The company provides inhalation anesthesia-related products, including anesthetic agents, which help meet the demand for surgical care. The diversified portfolio of hospitals and geographical presence make the company a major contributor to the global inhalation anesthesia marke
2. AbbVie Inc.
Headquarters: North Chicago, Illinois
The AbbVie Inc., founded in 2013 after being spun off from Abbott Laboratories, has over 50,000 employees worldwide and has reported revenue of about USD 58 billion in 2025. The company is also involved in the global inhalation anesthetics market with its anesthetic portfolio, including sevoflurane. Its strong R&D capabilities and distribution networks have contributed to the continuous need for its products, thus supporting its strategic position in hospital-based anesthesia care.
3. Fresenius Kabi AG
Headquarters: Bad Homburg, Germany
The Fresenius Kabi AG, founded in 1999, has more than 43,000 employees worldwide and reported revenue of around 9 billion USD in 2025. The company produces intravenous anesthetics and critical care products, which support inhalation anesthesia use in surgery. It has a strong distribution network in hospitals and increasing presence in emerging markets, making Fresenius Kabi AG a major facilitator in the global inhalation anesthesia market ecosystem.
4. Piramal Critical Care
Headquarters: Mumbai, India
The Piramal Critical Care, founded in 2010, has more than 1,000 employees globally and has reported revenue of around USD 350 million in 2025. The organization specializes in inhalation anesthetics, including sevoflurane and isoflurane, serving hospitals globally. The organization’s manufacturing capabilities and global presence make it a major contributor to the global inhalation anesthesia market’s growth.
5. Halocarbon Products Corporation
Headquarters: Peachtree Corners, Georgia
The Halocarbon Products Corporation, founded in 1950, has around 100-200 employees worldwide and generates an estimated revenue of 50-70 million USD in 2025. The company has expertise in fluorochemicals, which are required in the manufacturing process of inhalation anesthetics, including sevoflurane. The expertise in high-purity compounds makes Halocarbon Products Corporation a vital component in global supply chains, making it a crucial upstream player in the inhalation anesthesia market.
Are you ready to discover more about the Inhalation Anesthesia Market?
The report provides an in-depth analysis of the leading companies operating in the global Inhalation Anesthesia Market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Baxter International Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- AbbVie Inc.
- Fresenius Kabi AG
- Piramal Critical Care
- Halocarbon Products Corporation
- Hikma Pharmaceuticals PLC
- Merck KGaA
- Lunan Pharmaceutical Group
- Drägerwerk AG & Co. KGaA
- Others
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Inhalation Anesthesia Market
Conclusion
The global inhalation anesthetics market is expected to grow steadily with an increase in surgeries, an aging population, and better healthcare access in emerging markets. Technological developments, such as AI-assisted delivery systems and low-flow anesthesia technologies, are also driving the market. Moreover, sustainability trends, such as the elimination of high-global-warming-potential anesthetics, are also impacting the market. The European region is also an important contributor to the market due to better infrastructure and regulatory policies. The Asia-Pacific region is also expected to grow at a higher rate due to government initiatives and better healthcare infrastructure. Baxter International Inc., AbbVie Inc., and Fresenius Kabi AG are some of the major companies that are expanding their footprint in the market. Overall, the market is shifting towards sustainable and technology-based solutions to ensure long-term market growth and evolution.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
Need help to buy this report?